Interim report January – June 2026
Source: Cision
Q2 2026 revenue rose 23% to 1,041.4 MSEK (vs. 849.0 MSEK), while adjusted EBITA jumped 61% to 27.2 MSEK (16.9 MSEK). Order backlog increased to a record 7.3 billion SEK, improving visibility for future activity. Overall, the company is showing strong growth with materially improved profitability in the first half.
Analysis
The main implication is not the growth rate itself but the quality signal in the order book: sustained backlog expansion gives management a rare chance to de-risk revenue over the next 2-4 quarters and, if conversion holds, supports multiple expansion for an otherwise mid-cap/SMID industrial-services name. The market usually rewards this setup only after it sees that backlog turns into cash, not just EBITA, so the next check is working-capital discipline and whether incremental margins stay high as volume scales.
Second-order effects matter more than the print. If this company is pulling ahead on booked work, weaker peers likely face either pricing pressure or a slower pipeline as customers lock capacity early; that can widen the gap between high-quality operators and lower-quality contract-led competitors. The flip side is execution risk: backlog can be a trap if the mix is long-duration, low-margin, or labor-constrained, in which case current profitability is less durable than it appears.
Near term, the stock should remain supported for 1-3 months if order intake and margin commentary stay constructive, but the move is vulnerable if management signals slower conversion, higher wage inflation, or cash conversion below EBITA. Over 6-18 months, the thesis only works if the company proves it can convert the backlog without diluting margin or tying up too much capital; otherwise the market will re-rate it back toward a value trap. The consensus may be underestimating how quickly backlog quality can matter more than backlog size, especially in a slowing macro where customers can still delay starts even after booking work.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.60
Key Decisions for Investors
- No immediate trade on the headline alone; wait for the next quarterly update to confirm backlog conversion, gross margin stability, and operating cash flow before adding risk.
- If the company can be identified, consider a long/short against a lower-quality peer in the same Nordic industrial/services niche: long the highest-backlog, highest-conversion name; short the peer with weaker order coverage and worse cash conversion. Horizon: 1-3 months.
- Use this as a watch item for margin mean reversion: if the next print shows EBITA expanding faster than revenue again and cash flow follows, that is a credible 6-12 month multiple re-rating setup; if not, fade strength.
- For existing holders, keep a hard stop on any sign of backlog quality deterioration: guidance cut, weaker order intake, or working-capital outflow that implies the backlog is not monetizing.
More News
- Nasdaq Index: AI Selloff Deepens as Chips and CoreWeave Break
- AI stocks plunge. Inflation heats up. Where we're still finding opportunities
- Semiconductor market to remain solid ‘at least through next year,’ South Korea finance minister says
- Bending Spoons wants to revive software castoffs. Berkshire is backing the plan
- SpaceX’s ambitious, expensive gamble to replace AT&T, T-Mobile, and Verizon
- Why did CoreWeave stock get crushed this week? Look to this corner of the debt market for clues